Open AccessEarly Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review
Author(s) -
Michel Giunta,
Louis-Pierre Gauvin Meunier,
Donald R Nixon,
Jeff Steeves,
Jason Noble
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s376199
Subject(s) - medicine , macular degeneration , ophthalmology , visual acuity , ranibizumab , retrospective cohort study , confidence interval , branch retinal vein occlusion , retinal vasculitis , macular edema , aflibercept , retinal , vasculitis , surgery , bevacizumab , disease , chemotherapy